• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Hang Lee, PhD


  • Kandathil CK, Dilwali S, Wu CC, Ibrahimov M, McKenna MJ, Lee H, Stankovic KM.Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo.Otol. Neurotol. 2014 Feb;35(2):353-7.
  • Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U.A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer.Gynecol Oncol. 2014 Jan;132(1):55-60.
  • Liu JF, Tolaney SM, Birrer M, Fleming GF, Buss MK, Dahlberg SE, Lee H, Whalen C, Tyburski K, Winer E, Ivy P, Matulonis UA.A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.Eur J Cancer. 2013 Sep;49(14):2972-8.
  • Tapias LF, Mino-Kenudson M, Lee H, Wright C, Gaissert HA, Wain JC, Mathisen DJ, Lanuti M.Risk factor analysis for the recurrence of resected solitary fibrous tumours of the pleura: a 33-year experience and proposal for a scoring system.European Journal Of Cardio Thoracic Surgery : Official Journal Of The European Association For Cardio Thoracic Surgery. 2012 Dec 11.
  • Matulonis UA, Pereira L, Liu J, Lee H, Lee J, Whalen C, Campos S, Atkinson T, Hill M, Berlin S.Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer.Gynecol Oncol. 2012 Jul;126(1):41-6.
  • Kornblith AB, Mirabeau-Beale K, Lee H, Goodman AK, Penson RT, Pereira L, Matulonis UA.Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease.J Psychosoc Oncol. 2010 Sep;28(5):451-69.
  • Yu L, Jin W, Wang JX, Zhang X, Chen MM, Zhu ZH, Lee H, Lee M, Zhang YP.Characterization of TRPC2, an essential genetic component of VNS chemoreception, provides insights into the evolution of pheromonal olfaction in secondary-adapted marine mammals.Mol. Biol. Evol. 2010 Jul;27(7):1467-77.
  • Finkelstein JS, Wyland JJ, Lee H, Neer RM.Effects of Teriparatide, Alendronate, or Both in Women with Postmenopausal Osteoporosis.J Clin Endocrinol Metab. 2010 Apr;95(4):1838-45.
  • Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Cin PD, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR.B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.Am J Surg Pathol. 2010 Mar;34(3):327-40.
  • Roche MR, Rudd PJ, Krasner CN, Matulonis UA, Berlin ST, Lee H, Silver M, Tran CD, Seiden MV, Penson RT.Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.Gynecol Oncol. 2010 Feb;116(2):168-72.
  • Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM.Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors.J Clin Oncol. 2010 Jan 1;28(1):154-9.
  • Viswanathan AN, Cormack R, Rawal B, Lee H.Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer.Int J Gynecol Cancer. 2009 Nov;19(8):1402-6.
  • Valassi E, Swearingen B, Lee H, Nachtigall LB, Donoho DA, Klibanski A, Biller BM.Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.J Clin Endocrinol Metab. 2009 Dec;94(12):4851-9.
  • Burnett-Bowie SA, McKay EA, Lee H, Leder BZ.Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.J Clin Endocrinol Metab. 2009 Dec;94(12):4785-92.
  • Matulonis UA, Berlin S, Ivy P, Tyburski K, Krasner C, Zarwan C, Berkenblit A, Campos S, Horowitz N, Cannistra SA, Lee H, Lee J, Roche M, Hill M, Whalen C, Sullivan L, Tran C, Humphreys BD, Penson RT.Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer.J Clin Oncol. 2009 Nov 20;27(33):5601-6.
  • Liu JF, Hirsch MS, Lee H, Matulonis UA.Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.Gynecol Oncol. 2009 Dec;115(3):401-6.
  • Pitteloud N, Thambundit A, Dwyer AA, Falardeau JL, Plummer L, Caronia LM, Hayes FJ, Lee H, Boepple PA, Crowley WF.Role of seminiferous tubular development in determining the FSH versus LH responsiveness to GnRH in early sexual maturation.Neuroendocrinology. 2009;90(3):260-8.
  • Burnett-Bowie SA,Henao MP,Dere ME,Lee H,Leder BZ.Effects of hPTH(1-34) Infusion on Circulating Serum Phosphate, 1,25-Dihydroxyvitamin D and FGF23 Levels in Healthy Men.J Bone Miner Res. 2009 Oct;24(10):1681-5.
  • Lu W, Matulonis UA, Doherty-Gilman A, Lee H, Dean-Clower E, Rosulek A, Gibson C, Goodman A, Davis RB, Buring JE, Wayne PM, Rosenthal DS, Penson RT.Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial.J Altern Complement Med. 2009 Jul;15(7):745-53.
  • Finkelstein JS,Wyland JJ,Leder BZ,Burnett-Bowie SA,Lee H,Juppner H,Neer RM.Effects of teriparatide re-treatment in osteoporotic men and women.J Clin Endocrinol Metab. 2009 Jul;94(7):2495-501.
  • Mirabeau-Beale KL,Kornblith AB,Penson RT,Lee H,Goodman A,Campos SM,Duska L,Pereira L,Bryan J,Matulonis UA.Comparison of the quality of life of early and advanced stage ovarian cancer survivors.Gynecol Oncol. 2009 Aug;114(2):353-9.
  • Lee L,Garrett L,Lee H,Oliva E,Horowitz N,Duska LR.Association of clear cell carcinoma of the endometrium with a high rate of venous thromboembolism.J Reprod Med. 2009 Mar;54(3):133-8.
  • Dolan Looby SE,Collins M,Lee H,Grinspoon S.Effects of long-term testosterone administration in HIV-infected women: a randomized, placebo-controlled trial.AIDS. 2009 May 15;23(8):951-9.
  • Matulonis UA,Krag KJ,Krasner CN,Atkinson T,Horowitz NS,Lee H,Penson RT.Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors.Gynecol Oncol. 2009 Feb;112(2):394-9.
  • Stewart AJ, Cormack RA, Lee H, Xiong L, Hansen JL, O'Farrell DA, Viswanathan AN.Prospective Clinical Trial of Bladder Filling and Three-Dimensional Dosimetry in High-Dose-Rate Vaginal Cuff Brachytherapy.Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):843-8.
  • Matulonis UA,Horowitz NS,Campos SM,Lee H,Lee J,Krasner CN,Berlin S,Roche MR,Duska LR,Pereira L,Kendall D,Penson RT.Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.J Clin Oncol. 2008 Dec 10;26(35):5761-6.
  • Burnett-Bowie SA,Roupenian KC,Dere ME,Lee H,Leder BZ.Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.Clin Endocrinol (Oxf). 2008 Jun 25.
  • Pitteloud N, Dwyer AA, Decruz S, Lee H, Boepple PA, Crowley WF Jr, Hayes FJ.The Relative Role of Gonadal Sex Steroids and Gonadotropin-Releasing Hormone Pulse Frequency in the Regulation of FSH Secretion in Men.J Clin Endocrinol Metab. 2008 Jul;93(7):2686-92.
  • Triant VA,Brown TT,Lee H,Grinspoon SK.Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.J Clin Endocrinol Metab. 2008 Sep;93(9):3499-504.
  • Nachtigall L,Delgado A,Swearingen B,Lee H,Zerikly R,Klibanski A.Changing patterns in diagnosis and therapy of acromegaly over two decades.J Clin Endocrinol Metab. 2008 Jun;93(6):2035-41.
  • Smith MR,Lee H,McGovern F,Fallon MA,Goode M,Zietman AL,Finkelstein JS.Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.Cancer. 2008 May 15;112(10):2188-94.
  • Smith MR, Lee H, Fallon MA, Nathan DM.Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.Urology. 2008 Feb;71(2):318-22.
  • Huyck KL, Panhuysen CI, Cuenco KT, Zhang J, Goldhammer H, Jones ES, Somasundaram P, Lynch AM, Harlow BL, Lee H, Stewart EA, Morton CC.The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.Am J Obstet Gynecol. 2008 Feb;198(2):168.e1-9.
  • Pitteloud N, Dwyer AA, DeCruz S, Lee H, Boepple PA, Crowley WF Jr, Hayes FJ.Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men.J Clin Endocrinol Metab. 2008 Mar;93(3):784-91.
  • Cizek SM, Bedri S, Talusan P, Silva N, Lee H, Stone JR.Risk factors for atherosclerosis and the development of preatherosclerotic intimal hyperplasia.Cardiovasc Pathol. 2007 Nov-Dec;16(6):344-50.
  • Michaelson MD, Kaufman DS, Lee H, McGovern FJ, Kantoff PW, Fallon MA, Finkelstein JS, Smith MR.Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.J Clin Oncol. 2007 Mar 20;25(9):1038-42.
  • Matulonis UA, Campos S, Krasner CN, Duska LR, Penson RT, Falke R, Roche M, Smith LM, Lee H, Seiden MV, ,.Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: The modified triple doublet regimen.Gynecol Oncol. 2006 Nov;103(2):575-80.
  • Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV.Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.Clin Cancer Res. 2006 Sep 1;12(17):5055-63.
  • Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP.Influence of margin status and radiation on recurrence after radical hysterectomy in stage IB cervical cancer.Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1501-7.